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Colorectal cancer (CC), due to its frequency and social
costs is a subject of extensive screening programs (colo-
noscopy and new developments) in several countries,
including Poland. Relatively common and defined genetic
predispositions to different forms of CC make genetic
screening an attractive alternative, not only in families
with positive CC history. Optimal testing strategy should
be acceptable for subjects, high-throughput and cost-
effective in mutation detection.
CBDNA Ltd. Company has developed and validated
prototype diagnostic microarray test for genetic predispo-
sition to nonpolyposis colorectal cancer (HNPCC). The
test includes 169 selected mutations (point mutations
and short insertions/deletions) in 5 genes: MLH1, MSH2,
MSH6, CHEK2 and NOD2. Total of 36 patients with CC,
six of them fulfilling modified Amsterdam criteria for
HNPCC, and the rest with less evident familial aggrega-
tion of cancers were included in the pilot study. Alto-
gether 6 different mutations in 9 patients were identified
(25%) within the group.
The effectiveness of genetic screening using the microar-
ray method was similar to other molecular, but more
expensive and time-consuming methods.
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